Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
E Dahdouh1, S H Shoucair1, S E Salem1
1Clinical Microbiology Laboratory, Faculty of Medicine & Medical Science, University of Balamand, P.O. Box 100, Tripoli, Lebanon.
Abstract:
The aim of this study was to determine the usefulness of the MPC of carbapenems against clinical isolates of Pseudomonas spp. and Acinetobacter spp. and to assess its possible relationship with mechanisms of resistance. Detection of the mechanisms of resistance was performed using Antibiotic Susceptibility Testing, Double Disk Synergy, disk antagonism, addition of NaCl to the medium, addition of PBA or EDTA to Carbapenem disks, addition of PBA to Cefoxitin disks, and CCCP test for 10 Pseudomonas spp. and Acinetobacter baumannii strains. The MIC and MPC were determined using the broth macrodilution and plate dilution methods, respectively. Four Acinetobacter baumannii strains produced MBL. Two of them produced Oxacillinase and one produced ESBL. Two Pseudomonas spp. isolates produced both KPC and MBL. The resistant Acinetobacter spp. and Pseudomonas spp. strains had higher MPC values than susceptible ones. However, the Mutant Selection Window was found to be dependent on the degree of resistance but not on a particular mechanism of resistance. The usefulness of the MPC was found to be dependent on its value. Based on our data, we recommend determining the MPC for each isolate before using it during treatment. Furthermore, the use of T>MSW instead of T>MIC is suggested.
Insights
The mutant prevention concentration (MPC) of carbapenems is useful against resistant Pseudomonas and Acinetobacter. MPC values correlate with resistance levels, not specific resistance mechanisms, guiding optimal antibiotic therapy.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Carbapenem resistance in Pseudomonas spp. and Acinetobacter spp. poses a significant clinical challenge.
- Understanding resistance mechanisms is crucial for effective antimicrobial stewardship.
Purpose of the Study:
- To evaluate the utility of the mutant prevention concentration (MPC) of carbapenems against clinical isolates of Pseudomonas and Acinetobacter.
- To investigate the relationship between MPC and carbapenem resistance mechanisms.
Main Methods:
- Antibiotic Susceptibility Testing, Double Disk Synergy, and various phenotypic tests were used to detect resistance mechanisms.
- Minimum Inhibitory Concentration (MIC) and MPC were determined via broth macrodilution and plate dilution.
- Tested 10 clinical isolates of Pseudomonas spp. and Acinetobacter baumannii.
Main Results:
- Four Acinetobacter baumannii strains produced MBL, two Oxacillinase, and one ESBL. Two Pseudomonas spp. isolates produced both KPC and MBL.
- Resistant strains exhibited higher MPC values compared to susceptible strains.
- Mutant Selection Window (MSW) depended on the degree of resistance, not specific mechanisms.
Conclusions:
- The usefulness of MPC is value-dependent and recommended for individual isolate assessment before treatment.
- Therapeutic strategies should consider T>MSW (time above mutant selection window) over T>MIC (time above minimum inhibitory concentration).
Related Concept Videos
Pharmacodynamic Models: Overview
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA


